UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 81

Sortiert nach

Eculizumab for Congenital Atypical Hemolytic–Uremic Syndrome

The New England journal of medicine, 2009-01, Vol.360 (5), p.544-546

2009

Link zum Volltext

Verfügbarkeit prüfen

Atypical Hemolytic Uremic Syndrome

The Pediatric clinics of North America, 2018-06, Vol.65 (3), p.509-525

2018

Link zum Volltext

Verfügbarkeit prüfen

Integrin αIIb-mediated PI3K/Akt activation in platelets

PloS one, 2012-10, Vol.7 (10), p.e47356-e47356

2012

Link zum Volltext

Verfügbarkeit prüfen

Outcomes in children with deep vein thrombosis managed with percutaneous endovascular thrombolysis

Pediatric radiology, 2015-04, Vol.45 (5), p.719-726

2015

Link zum Volltext

Verfügbarkeit prüfen

Treatment of hemophilia in developing countries: A journey of a thousand miles

Pediatric blood & cancer, 2010-03, Vol.54 (3), p.348-349

Gruppo, Ralph A.

2010

Link zum Volltext

Verfügbarkeit prüfen

Legg-Calve-Perthes disease and thrombophilia

Journal of bone and joint surgery. American volume, 2004-12, Vol.86 (12), p.2642

2004

Link zum Volltext

Verfügbarkeit prüfen

The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults

Thrombosis and haemostasis, 1999-05, Vol.81 (5), p.739

1999

Link zum Volltext

Verfügbarkeit prüfen

Clinical and positron emission tomography findings of chorea associated with primary antiphospholipid antibody syndrome

Movement disorders, 2007-09, Vol.22 (12), p.1813-1815

2007

Link zum Volltext

Verfügbarkeit prüfen

The β3 subunit of the integrin αIIbβ3 regulates αIIb-mediated outside-in signaling

Blood, 2005-06, Vol.105 (11), p.4345-4352

2005

Link zum Volltext

Verfügbarkeit prüfen

The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis

Clinical orthopaedics and related research, 1999-09, Vol.366 (366), p.133-146

1999

Link zum Volltext

Verfügbarkeit prüfen

Abnormally sialylated fibrinogen γ-chains in a patient with chronic thromboembolic pulmonary hypertension

Thrombosis research, 2007-01, Vol.119 (2), p.257-259

2007

Link zum Volltext

Verfügbarkeit prüfen

Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2022-01, Vol.327 (2), p.129

2022

Link zum Volltext

Verfügbarkeit prüfen

Favorable histology, MYCN-amplified 4S neonatal neuroblastoma

Pediatric Blood & Cancer, 2007-04, Vol.48 (4), p.479-482

2007

Link zum Volltext

Verfügbarkeit prüfen

Atypical haemolytic uraemic syndrome in a patient with sickle cell disease, successfully treated with eculizumab

British journal of haematology, 2016-11, Vol.175 (4), p.744-747

2016

Link zum Volltext

Verfügbarkeit prüfen

Perioperative haemostasis with full‐length, PEGylated, recombinant factor VIII with extended half‐life (rurioctocog alfa pegol) in patients with haemophilia A: Final results of a multicentre, single‐arm phase III trial

Haemophilia : the official journal of the World Federation of Hemophilia, 2019-09, Vol.25 (5), p.773-781

2019

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Multiple Electrode Impedance-Based Platelet Aggregometry to Light Transmission Aggregometry for Diagnosis of Qualitative Platelet Defects

Blood, 2017-12, Vol.130, p.1048-1048

2017

Link zum Volltext

Verfügbarkeit prüfen

The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort

Blood, 2013-02, Vol.121 (8), p.1446-1454

2013

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Outcome in a Pediatric Patient with Atypical Hemolytic Uremic Syndrome (aHUS) with Sustained Eculizumab (ECU) Treatment

Blood, 2011-11, Vol.118 (21), p.4682-4682

2011

Link zum Volltext

Verfügbarkeit prüfen

Developing a pediatric endovascular thrombolysis program: a single-center experience

Pediatric radiology, 2013-08, Vol.43 (8), p.1024-1029

2013

Link zum Volltext

Verfügbarkeit prüfen

BAY 81-8973 safety and efficacy for prophylaxis and treatment of bleeds in previously treated children with severe haemophilia A: results of the LEOPOLD Kids Trial

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-05, Vol.22 (3), p.354-360

2016

Link zum Volltext

Verfügbarkeit prüfen

Data Coming out of the Human Inhibitor PUP Study (HIPS) Reveal 4 Subgroups of Patients with Distinct Antibody Signatures

Blood, 2018-11, Vol.132 (Supplement 1), p.3774-3774

2018

Link zum Volltext

Verfügbarkeit prüfen

Perioperative Efficacy of an Extended Half-Life, Pegylated, Full-Length, Recombinant Factor VIII (BAX 855) in Individual Procedures

Blood, 2015-12, Vol.126 (23), p.2299-2299

2015

Link zum Volltext

Verfügbarkeit prüfen

Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening

Transfusion (Philadelphia, Pa.), 2013-06, Vol.53 (6), p.1217-1225

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(71)

Publikationsform

Artikel
(80)
Berichte
(1)

Sprache

Englisch
(81)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Eculizumab for Congenital Atypical Hemolytic–Uremic Syndrome

Atypical Hemolytic Uremic Syndrome

Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States

Integrin αIIb-mediated PI3K/Akt activation in platelets

Outcomes in children with deep vein thrombosis managed with percutaneous endovascular thrombolysis

Treatment of hemophilia in developing countries: A journey of a thousand miles

Legg-Calve-Perthes disease and thrombophilia

The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults

Clinical and positron emission tomography findings of chorea associated with primary antiphospholipid antibody syndrome

The β3 subunit of the integrin αIIbβ3 regulates αIIb-mediated outside-in signaling

The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis

Abnormally sialylated fibrinogen γ-chains in a patient with chronic thromboembolic pulmonary hypertension

Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial

Favorable histology, MYCN-amplified 4S neonatal neuroblastoma

Atypical haemolytic uraemic syndrome in a patient with sickle cell disease, successfully treated with eculizumab

Perioperative haemostasis with full‐length, PEGylated, recombinant factor VIII with extended half‐life (rurioctocog alfa pegol) in patients with haemophilia A: Final results of a multicentre, single‐arm phase III trial

Comparison of Multiple Electrode Impedance-Based Platelet Aggregometry to Light Transmission Aggregometry for Diagnosis of Qualitative Platelet Defects

The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort

Long-Term Outcome in a Pediatric Patient with Atypical Hemolytic Uremic Syndrome (aHUS) with Sustained Eculizumab (ECU) Treatment

Developing a pediatric endovascular thrombolysis program: a single-center experience

BAY 81-8973 safety and efficacy for prophylaxis and treatment of bleeds in previously treated children with severe haemophilia A: results of the LEOPOLD Kids Trial

Data Coming out of the Human Inhibitor PUP Study (HIPS) Reveal 4 Subgroups of Patients with Distinct Antibody Signatures

Perioperative Efficacy of an Extended Half-Life, Pegylated, Full-Length, Recombinant Factor VIII (BAX 855) in Individual Procedures

Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening

Longitudinal Antibody Signatures Following FVIII Replacement Therapy in Previously Untreated Patients with Severe Hemophilia Α- New Insights from the Hemophilia Inhibitor PUP Study (HIPS)

Suchergebnisse filtern